These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 32295876

  • 1. The CD137 Ligand Is Important for Type 1 Diabetes Development but Dispensable for the Homeostasis of Disease-Suppressive CD137+ FOXP3+ Regulatory CD4 T Cells.
    Foda BM, Ciecko AE, Serreze DV, Ridgway WM, Geurts AM, Chen YG.
    J Immunol; 2020 Jun 01; 204(11):2887-2899. PubMed ID: 32295876
    [Abstract] [Full Text] [Related]

  • 2. CD137 Plays Both Pathogenic and Protective Roles in Type 1 Diabetes Development in NOD Mice.
    Forsberg MH, Ciecko AE, Bednar KJ, Itoh A, Kachapati K, Ridgway WM, Chen YG.
    J Immunol; 2017 May 15; 198(10):3857-3868. PubMed ID: 28363905
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Regulatory T Cells Inhibit T Cell Activity by Downregulating CD137 Ligand via CD137 Trogocytosis.
    Luu K, Patwardhan MV, Zeng Q, Wickström SL, Lundqvist A, Schwarz H.
    Cells; 2021 Feb 09; 10(2):. PubMed ID: 33572150
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment.
    Bresson D, Fousteri G, Manenkova Y, Croft M, von Herrath M.
    J Autoimmun; 2011 Dec 09; 37(4):342-51. PubMed ID: 22063316
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of the CD137 ligand (CD137L) signaling pathway during Mycobacterium tuberculosis infection.
    Martínez Gómez JM, Koh VH, Yan B, Lin W, Ang ML, Rahim SZ, Pethe K, Schwarz H, Alonso S.
    Immunobiology; 2014 Jan 09; 219(1):78-86. PubMed ID: 24091276
    [Abstract] [Full Text] [Related]

  • 15. Transient Depletion of Foxp3+ Regulatory T Cells Selectively Promotes Aggressive β Cell Autoimmunity in Genetically Susceptible DEREG Mice.
    Watts D, Janßen M, Jaykar M, Palmucci F, Weigelt M, Petzold C, Hommel A, Sparwasser T, Bonifacio E, Kretschmer K.
    Front Immunol; 2021 Jan 09; 12():720133. PubMed ID: 34447385
    [Abstract] [Full Text] [Related]

  • 16. CD137-CD137L interaction regulates atherosclerosis via cyclophilin A in apolipoprotein E-deficient mice.
    Li Y, Yan J, Wu C, Wang Z, Yuan W, Wang D.
    PLoS One; 2014 Jan 09; 9(2):e88563. PubMed ID: 24520398
    [Abstract] [Full Text] [Related]

  • 17. Allergen-specific immunotherapy enhances CD8+  CD25+  CD137+ regulatory T cells and decreases nasal nitric oxide.
    Tsai YG, Yang KD, Wen YS, Hung CH, Chien JW, Lin CY.
    Pediatr Allergy Immunol; 2019 Aug 09; 30(5):531-539. PubMed ID: 30968455
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
    Ly D, Mi QS, Hussain S, Delovitch TL.
    J Immunol; 2006 Sep 15; 177(6):3695-704. PubMed ID: 16951329
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.